Particle.news

Brazil Records First Mpox Death as Cases Top 1,000

Expanded targeted vaccination for high‑risk groups responds to a recent surge concentrated in Rio de Janeiro and São Paulo.

Overview

  • Health authorities confirmed the country’s first mpox death in mid-November, a Rio de Janeiro resident who had a preexisting immunosuppressive condition.
  • National monitoring shows more than 1,000 confirmed mpox cases in 2026 with notifications accelerating since October and October–early November accounting for a large share of new diagnoses.
  • Cases are concentrated mainly in Rio de Janeiro and São Paulo, with Rio reporting several hundred infections in 2026 and most municipal cases clustered in the capital.
  • State laboratories have detected MPXV subtype 1b in multiple localities, prompting stepped-up genomic surveillance to track whether this lineage is driving transmission or severity changes.
  • The Ministry of Health purchased 25,000 vaccine doses with delivery expected in about three weeks and states have begun targeted two-dose vaccination for defined high-risk groups under a 28-day interval.